World7 months ago
Long-Term, Real-World Data Support Ibrutinib Efficacy, Safety in CLL
Final results of the EVIdeNCE study strongly support ibrutinib (Imbruvica; AbbVie/Pharmacyclics) as a valuable treatment option for patients with chronic lymphocytic leukemia (CLL). The EVIdeNCE data,...
